|
Real-time
Boerse Muenchen
10:13:34 2024-10-31 EDT
|
5-day change | 1st Jan Change | ||
| 2.180 EUR | +21.79% |
|
-.--% | - |
Company Valuation: TFF Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 |
|---|---|
| Market Cap 1 | 17.05 |
| Change | - |
| Enterprise Value (EV) 1 | 11.68 |
| Change | - |
| P/E | -0.61x |
| PBR | 1.79x |
| PEG | 0x |
| Capitalization / Revenue | 23,228,288x |
| EV / Revenue | - |
| EV / EBITDA | - |
| EV / EBIT | -0.53x |
| EV / FCF | - |
| FCF Yield | - |
| Dividend per Share 2 | - |
| Rate of return | - |
| EPS 2 | -11.85 |
| Distribution rate | - |
| Net sales | 0.7339 |
| EBITDA | -21.39 |
| EBIT 1 | -21.89 |
| Net income 1 | -21.24 |
| Net Debt 1 | -5.363 |
| Reference price 2 | 7.207 |
| Nbr of stocks (in thousands) | 2,365 |
| Announcement Date | 3/28/24 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 11.24M | |
| 31.04x | 5.6x | 16.76x | 1.05% | 45.48B | |
| -20.85x | 240.83x | -22.36x | -.--% | 43.68B | |
| 33.71x | 3.27x | 14.1x | -.--% | 43.09B | |
| 45.39x | 5.23x | 28.64x | -.--% | 39.4B | |
| 27.03x | 8.15x | 20.66x | 0.42% | 31.91B | |
| 33.41x | 5.47x | 24.85x | -.--% | 16.4B | |
| 23.57x | 2.06x | 8.94x | 1.13% | 14.24B | |
| 74.44x | 3.94x | 15.27x | -.--% | 13.28B | |
| Average | 30.97x | 34.32x | 13.36x | 0.33% | 27.5B | |
| Weighted average by Cap. | 26.17x | 46.68x | 11.79x | 0.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 0K30 Stock
- Valuation TFF Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
